Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience-Reference-Cited by-同舟云学术

Efficacy and Tolerability of Biweekly Bevacizumab, Irinotecan, Folinic Acid and Fluorouracil Intravenous Bolus (BIFF Regimen) in Patients With Metastatic Colorectal Cancer: The Southern Italy Cooperative Oncology Group Experience

Published:2011-03 Issue:1 Volume:10 Page:42-47
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Comella Pasquale,Massidda Bruno,Natale Donato,Putzu Carlo,Sandomenico Claudia,Filippelli Gianfranco,Palmeri Sergio,Condemi Giovanni,Vessia Giacomo,Barberis Giuseppe,Ionta Maria Teresa,Tafuto Salvatore,Barbato Enrico

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference24 articles.

1. Angiogenesis in cancer and other disease;Carmeliet;Nature,2000

2. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis;Hicklin;J Clin Oncol,2005

3. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors;Tong;Cancer Res,2004

4. Kinetics of vascular normalization by VEGFR2 blockade governs tumor response to radiation;Winkler;Cancer Cell,2004

5. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11;Wildiers;Br J Cancer,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-03

2. Bevacizumab/fluorouracil/folinic acid/irinotecan;Reactions Weekly;2015-05

3. Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy;Nanomedicine;2011-11